Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,539,609
-
Share change
-
-5,782,524
-
Total reported value
-
$4,161,105
-
Put/Call ratio
-
5%
-
Price per share
-
$0.22
-
Number of holders
-
40
-
Value change
-
-$1,602,213
-
Number of buys
-
9
-
Number of sells
-
27
Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) as of Q4 2023
As of 31 Dec 2023,
EIGER BIOPHARMACEUTICALS INC - COM (EIGR) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,539,609 shares.
The largest 10 holders included
AMERIPRISE FINANCIAL INC, Propel Bio Management, LLC, 683 Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, RBF Capital, LLC, ACADIAN ASSET MANAGEMENT LLC, and STATE STREET CORP.
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.